Skinbiotherapeutics Share Discussion Threads

[polus] 04/12/2017 17:17

Let's see if you get the message too, mate.

[bobalot] 04/12/2017 16:40

It looks like the OPTI MOB have got the message perhaps...discussions about SkinBio most welcome.

[elrico] 04/12/2017 14:41

A reasonable request - Polus.

[polus] 04/12/2017 14:32

So, my advice, if you're not saying anything NEW..probably best to say nothing and just patiently wait. Take it or leave it.

[bobalot] 04/12/2017 14:22

Try looking at all the rubbish the OPTI MOB posted.

A discussion about the latest news would be more interesting.

[polus] 04/12/2017 14:11

I agree with you, but I think you need to see that your posts are having a negative impact, not a positive one. You seem blind to the fact that it's you that is bringing negativity to the board. The RNS was posted by someone on Friday, but since then you've re-posted it several times and I don't understand why? You seem to fear the board being left without news for a few days, and seem to feel the need to repeat things in some attempt to make things look fresh. It's only Monday! I've been trying to get a friend to invest but all she's done is tell me she thinks you're a fraud. Personally, I don't think you are, but your CONSTANT reposting of news is coming across extremely desperate and of a ramping nature. So, there you have it, you're putting investors off, congrats.

[bobalot] 04/12/2017 14:01

SkinBio have a global market I the making imo.

[polus] 04/12/2017 14:00

Why do you keep posting old news?

[bobalot] 04/12/2017 13:59

Here is a recap about last Fridays RNS because the thread is filled with nonsense from that crazy OPTI MOB:

SkinBioTherapeutics PLC Notification of first patent grant 01/12/2017 7:05am
UK Regulatory (RNS & others)

Notification of first patent grant

Manchester, UK - 1 December 2017 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces the granting of the first patent for its SkinBiotix(R) technology in Australia.

The patent granted covers the use of specific probiotic bacteria and lysates in the treatment of skin in health and disease.

This marks the Company's first patent to progress to grant from within its portfolio of patents pending estate. The patent, numbered 2013246701 and entitled 'Probiotic bacteria', runs until 15 March 2033.
The patent is in active prosecution in other locations worldwide including Europe, USA and China.

Dr Catherine O'Neill, CEO of SkinBioTherapeutics, commented:

"The Australian skincare market is a key global market. The progression and successful grant of the first national patent to emerge from the Company's Skinbiotix(R) patent family underpins the commercial potential worldwide.

"This is a step forward in preparing for human trials, which are scheduled for 2018."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
-Ends-

[bobalot] 04/12/2017 13:55

elrico 4 Dec '17 - 13:16 - 1082 of 1083 0 0 (Filtered)
Asterix96 4 Dec '17 - 13:48 - 1083 of 1083 0 0 (Filtered)

The opti mobsters are back with their utter nonsense and fake intel.

I don't believe a word those characters write anymore...NOT BELIEVEABLE POSTERS imo.

[asterix96] 04/12/2017 13:48

The filter helps with the hypertension, along with the LDL-Control!

elrico your reward is the peace and quiet!

[elrico] 04/12/2017 13:16

I can confirm it works, though I'm well into double digits with both BB's - Asterix, do I get a prize or bliss reward enough? ;)

[asterix96] 04/12/2017 12:27

My filter is doing a fantastic job! Caught 7 bobalots today! Try it and save yourself a lot of boba!

[bobalot] 04/12/2017 12:06

There PRODUCTS HAVE commercial potential worldwide.

And that is what the company have plans for....making a lot of money for investors and themselves. Along with solving skin related medical problems.



loungeact 4 Dec '17 - 12:07 - 1079 of 1079 0 0 (Filtered)

[bobalot] 04/12/2017 12:04

GOOD NEW THOUGH FROM SKINBIO:

Catherine O'Neill, SkinBioTherapeutics’ chief executive, said: "The Australian skincare market is a key global market.

“The progression and successful grant of the first national patent to emerge from the company's Skinbiotix patent family underpins the commercial potential worldwide.

"This is a step forward in preparing for human trials, which are scheduled for 2018."

[bobalot] 04/12/2017 12:02

I shall explain...dipsticks often don't realise when they have something and yet nothing. THE OPTI MOB ARE RATHER LIKE THAT AND SO ARE YOU.

[1bokke] 04/12/2017 11:49

I have disturbing news and proof positive that Bobs posts are harmful... I read Bobs posts out loud and Oscar my beloved fish threw himself out of his tank.. Bob, all I have left is a box of water:'(

[bobalot] 04/12/2017 11:44

elrico 4 Dec '17 - 11:39 - 1072 of 1073 0 0 (Filtered)

complete and utter rubbish... you actually wrote reams about SBTX being a subsidiary.
An approach of discrediting others imo then the mob follow.

[bobalot] 04/12/2017 11:41

Selling the first product in China is most definitely on the cards..post patent registration. That's the largest market in the world and it happens to be upwardly mobile with a middle class population in excess of 500 million.


SBTX is planning global distribution through a big brand name imo.

The patent is in active prosecution in other locations worldwide including Europe, USA and China.

They all equate to the largest and more affluent population centres.

Everything is looking good so far for SBTX clinical and cosmetic creams imo.